Emcure Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2025 ,inter alia, to consider and approve unaudited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2024. The trading window for dealing in securities of the Company by the Designated Persons and their relatives has been already closed from January 01, 2025, as communicated earlier vide our letter No. EPL/CS/SE/0033/2024 dated December 18, 2024 and shall remain closed till 48 hours after the declaration of the financial results i.e. till February 08, 2025, in terms of the Company's Code of Conduct for regulating, monitoring and reporting of insider trading in the securities of the Company, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended.